FFCP PHASE1:Mm9::chr11:43412172..43412177,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=131|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr11:43412172..43412177,-|id=chr11:43412172..43412177,-|ontology_enrichment_celltype=CL:0000473!1.73e-15!3;CL:0000627!1.73e-15!3;CL:0000682!1.73e-15!3|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000331!3.67e-34!3;UBERON:0002116!3.67e-34!3;UBERON:0001204!3.67e-34!3;UBERON:0001168!3.67e-34!3;UBERON:0000344!2.53e-26!15;UBERON:0001962!3.81e-22!2;UBERON:0001961!3.81e-22!2;UBERON:0001744!3.81e-22!2;UBERON:0004923!1.56e-16!24;UBERON:0002465!3.97e-15!3;UBERON:0001242!3.84e-14!13;UBERON:0000060!3.84e-14!13;UBERON:0001262!3.84e-14!13;UBERON:0004786!3.84e-14!13;UBERON:0003199!5.53e-12!1;UBERON:0002108!5.79e-07!16|ontology_enrichment_uberon_v019_2=UBERON:0000331,1.58e-86,3;UBERON:0002116,1.58e-86,3;UBERON:0001204,1.58e-86,3;UBERON:0001168,1.58e-86,3;UBERON:0002108,2.83e-65,4;UBERON:0001242,5.26e-21,13;UBERON:0001262,5.26e-21,13;UBERON:0004786,5.26e-21,13;UBERON:0000344,2.29e-18,15;UBERON:0004923,6.63e-12,24;UBERON:0000160,1.87e-09,31|phase1_expression=0,0,0,0.60492842261366,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.319984845586813,0.45881856213434,0.57423196411502,0,0.646413698057667,3.80046838912748,1.51218077855958,1.10865255327652,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr11:43412172..43412177,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=131 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr11:43412172..43412177,- | |||
|description=CAGE_peak_at_chr11:43412172..43412177,- | |||
|id=chr11:43412172..43412177,- | |||
|ontology_enrichment_celltype=CL:0000473!1.73e-15!3;CL:0000627!1.73e-15!3;CL:0000682!1.73e-15!3 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000331!3.67e-34!3;UBERON:0002116!3.67e-34!3;UBERON:0001204!3.67e-34!3;UBERON:0001168!3.67e-34!3;UBERON:0000344!2.53e-26!15;UBERON:0001962!3.81e-22!2;UBERON:0001961!3.81e-22!2;UBERON:0001744!3.81e-22!2;UBERON:0004923!1.56e-16!24;UBERON:0002465!3.97e-15!3;UBERON:0001242!3.84e-14!13;UBERON:0000060!3.84e-14!13;UBERON:0001262!3.84e-14!13;UBERON:0004786!3.84e-14!13;UBERON:0003199!5.53e-12!1;UBERON:0002108!5.79e-07!16 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000331,1.58e-86,3;UBERON:0002116,1.58e-86,3;UBERON:0001204,1.58e-86,3;UBERON:0001168,1.58e-86,3;UBERON:0002108,2.83e-65,4;UBERON:0001242,5.26e-21,13;UBERON:0001262,5.26e-21,13;UBERON:0004786,5.26e-21,13;UBERON:0000344,2.29e-18,15;UBERON:0004923,6.63e-12,24;UBERON:0000160,1.87e-09,31 | |||
|phase1_expression=0,0,0,0.60492842261366,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.319984845586813,0.45881856213434,0.57423196411502,0,0.646413698057667,3.80046838912748,1.51218077855958,1.10865255327652,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr11:43412172..43412177,- | |||
}} |
Latest revision as of 22:13, 5 August 2015
Short description: | p@chr11:43412172..43412177, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr11:43412172..43412177, - |
Coexpression cluster: | MCL_coexpression_mm9:131 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
ileal mucosa | 1.58e-86 | 3 |
ileum | 1.58e-86 | 3 |
mucosa of small intestine | 1.58e-86 | 3 |
wall of small intestine | 1.58e-86 | 3 |
small intestine | 2.83e-65 | 4 |
intestinal mucosa | 5.26e-21 | 13 |
wall of intestine | 5.26e-21 | 13 |
gastrointestinal system mucosa | 5.26e-21 | 13 |
mucosa | 2.29e-18 | 15 |
organ component layer | 6.63e-12 | 24 |
intestine | 1.87e-09 | 31 |